These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 11913388

  • 1. Predicted solution structure of zymogen human coagulation FVII.
    Perera L, Darden TA, Pedersen LG.
    J Comput Chem; 2002 Jan 15; 23(1):35-47. PubMed ID: 11913388
    [Abstract] [Full Text] [Related]

  • 2. Solution structure of the N-terminal EGF-like domain from human factor VII.
    Muranyi A, Finn BE, Gippert GP, Forsén S, Stenflo J, Drakenberg T.
    Biochemistry; 1998 Jul 28; 37(30):10605-15. PubMed ID: 9692950
    [Abstract] [Full Text] [Related]

  • 3. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV, Petrovan RJ, Ruf W, Olson AJ.
    Proteins; 2003 Nov 15; 53(3):640-8. PubMed ID: 14579355
    [Abstract] [Full Text] [Related]

  • 4. Four loops of the catalytic domain of factor viia mediate the effect of the first EGF-like domain substitution on factor viia catalytic activity.
    Jin J, Perera L, Stafford D, Pedersen L.
    J Mol Biol; 2001 Apr 13; 307(5):1503-17. PubMed ID: 11292356
    [Abstract] [Full Text] [Related]

  • 5. The effect of O-fucosylation on the first EGF-like domain from human blood coagulation factor VII.
    Kao YH, Lee GF, Wang Y, Starovasnik MA, Kelley RF, Spellman MW, Lerner L.
    Biochemistry; 1999 Jun 01; 38(22):7097-110. PubMed ID: 10353820
    [Abstract] [Full Text] [Related]

  • 6. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF, Yang J, Eigenbrot C, Moran P, Peek M, Lipari MT, Kirchhofer D.
    Biochemistry; 2004 Feb 10; 43(5):1223-9. PubMed ID: 14756558
    [Abstract] [Full Text] [Related]

  • 7. Crystal structure of active site-inhibited human coagulation factor VIIa (des-Gla).
    Kemball-Cook G, Johnson DJ, Tuddenham EG, Harlos K.
    J Struct Biol; 1999 Oct 10; 127(3):213-23. PubMed ID: 10544046
    [Abstract] [Full Text] [Related]

  • 8. Probing the structural changes in the light chain of human coagulation factor VIIa due to tissue factor association.
    Perera L, Darden TA, Pedersen LG.
    Biophys J; 1999 Jul 10; 77(1):99-113. PubMed ID: 10388743
    [Abstract] [Full Text] [Related]

  • 9. The solution structure of human coagulation factor VIIa in its complex with tissue factor is similar to free factor VIIa: a study of a heterodimeric receptor-ligand complex by X-ray and neutron scattering and computational modeling.
    Ashton AW, Boehm MK, Johnson DJ, Kemball-Cook G, Perkins SJ.
    Biochemistry; 1998 Jun 02; 37(22):8208-17. PubMed ID: 9609717
    [Abstract] [Full Text] [Related]

  • 10. Influence of cofactor binding and active site occupancy on the conformation of the macromolecular substrate exosite of factor VIIa.
    Dickinson CD, Shobe J, Ruf W.
    J Mol Biol; 1998 Apr 10; 277(4):959-71. PubMed ID: 9545384
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Structure and dynamics of zymogen human blood coagulation factor X.
    Venkateswarlu D, Perera L, Darden T, Pedersen LG.
    Biophys J; 2002 Mar 10; 82(3):1190-206. PubMed ID: 11867437
    [Abstract] [Full Text] [Related]

  • 13. Model of a ternary complex between activated factor VII, tissue factor and factor IX.
    Chen SW, Pellequer JL, Schved JF, Giansily-Blaizot M.
    Thromb Haemost; 2002 Jul 10; 88(1):74-82. PubMed ID: 12152682
    [Abstract] [Full Text] [Related]

  • 14. Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency.
    Peyvandi F, Jenkins PV, Mannucci PM, Billio A, Zeinali S, Perkins SJ, Perry DJ.
    Thromb Haemost; 2000 Aug 10; 84(2):250-7. PubMed ID: 10959697
    [Abstract] [Full Text] [Related]

  • 15. Structural modulation of factor VIIa by full-length tissue factor (TF1-263): implication of novel interactions between EGF2 domain and TF.
    Prasad R, Sen P.
    J Biomol Struct Dyn; 2018 Feb 10; 36(3):621-633. PubMed ID: 28150568
    [Abstract] [Full Text] [Related]

  • 16. The factor VII zymogen structure reveals reregistration of beta strands during activation.
    Eigenbrot C, Kirchhofer D, Dennis MS, Santell L, Lazarus RA, Stamos J, Ultsch MH.
    Structure; 2001 Jul 03; 9(7):627-36. PubMed ID: 11470437
    [Abstract] [Full Text] [Related]

  • 17. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation.
    Orning L, Fischer PM, Hu CK, Agner E, Engebretsen M, Husbyn M, Petersen LB, Orvim U, Llinas M, Sakariassen KS.
    Thromb Haemost; 2002 Jan 03; 87(1):13-21. PubMed ID: 11848442
    [Abstract] [Full Text] [Related]

  • 18. Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
    Huang H, Norledge BV, Liu C, Olson AJ, Edgington TS.
    Biochemistry; 2003 Sep 16; 42(36):10619-26. PubMed ID: 12962485
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.